CMS denies off-label Actiq coverage
The latest shot in the battle against drug costs comes from the Centers for Medicaid and Medicare Services, which is reported to be denying coverage for off-label use of drugs such as Actiq and Fentora. Whenever CMS moves, the healthcare … Continue reading CMS denies off-label Actiq coverage
Read More...